We describe a novel array for accurate and reliable genotyping of human papillomavirus (HPV) using peptide nucleic acid (PNA) probes. In order to exploit the superior hybridization properties of PNA with target HPV DNAs, we developed a novel PNA array (PANArray HPV). PANArray HPV enables the detection and genotyping of HPVs using 32 type-specific PNA capture probes for medically important HPVs. All tested HPV types showed highly unique hybridization patterns with type-specific PNA probes. PNA array results showed stable specificities and sensitivities after up to 13 months of storage at room temperature. Also, we demonstrated the superior specificity, sensitivity, and stability of PNA arrays for HPV genotyping. We compared the genotyping results of the PNA array to sequencing with MY09/11 PCR products derived from 72 clinical samples. The results showed excellent agreement between the PNA array and sequencing, except for samples reflecting multiple infections. The results from the PNA array were compared with those of type-specific PCR when discrepant results occurred owing to multiple infections. The results for the PNA array matched those of type-specific PCR in all cases. Newly developed PNA arrays show excellent specificity and sensitivity and long shelf life. Our results suggest that the PNA array represents a reliable alternative to conventional DNA arrays for HPV genotyping, as well as for diagnostics.Human papillomaviruses (HPVs) comprise more than 100 genotypes, of which over 30 types are associated with sexually transmitted infections. The mucosal types can be divided into high-risk and low-risk types depending on the associated disease risk. HPV infection is a necessary prerequisite for cervical cancer development. Accurate HPV genotyping is increasingly important for investigating the clinical outcomes and epidemiologies of particular types, for the characterization of study populations in HPV vaccination trials, and for monitoring the efficacies of HPV vaccines (17,20).Members of the HPV family do not lend themselves to culture in vitro. Thus, detection of HPV is restricted to molecular analyses of HPV DNA sequences (10). Technical improvements in PCR, sequencing, and hybridization assays (ThirdWave Technology hybrid capture, linear array, and oligonucleotide arrays) have increased the sensitivity, specificity, and speed of assays. Although this technology has many advantages, and several working systems have been established, their sensitivity, reproducibility, and reliability are still major issues (6,8,11,21,26). Most platforms that have been described make use of natural DNA or RNA as capture probes. However, several nucleic acid analogs have demonstrated more favorable hybridization characteristics than standard DNA-based probes. Nucleic acid analogs have been made in order to overcome the limitations of natural nucleic acids for specificity, sensitivity, hybridization kinetics, thermodynamic properties, and stability (2,4,12).Peptide nucleic acids (PNAs) are notable for their exceptional biolo...